Show results for
Refine by
Applications
- FluidFM for CRISPR cell line development Accelerate your CRISPR gene editing and cell line engineering
- Single-cell omics with Live-seq
- Mechanobiology and single-cell adhesion measurements with FluidFM
- FluidFM for Neuroscience Pattern, stimulate, inject into, and analyze single neurons
- FluidFM for Virology Study viral entry and replication on a single virion-single cell level
- Excitation-Contraction-Energy (ECE) Coupling Analysis for Cardiac Physiology
Disease Insect Models Services Available In Iran
29 services found
Manufactured by:Curi Bio based inSeattle, WASHINGTON (USA)
Curi Bio’s iPSC Repositories Available for Services. Custom Panel of Different Gender and Ethnicities. Disease Model Pairs. Patient-derived iPSC-lines. Isogenic DMD/WT Myoblasts. Isogenic DMD/WT ...
Manufactured by:TissUse GmbH based inBerlin, GERMANY
TissUse offers high-value service contracts to create custom solutions for safety evaluation of drugs, cosmetics and chemicals, and pre-clinical human disease modelling. Any new chip design serving customer needs with a specific organ arrangement can be prototyped and produced at short notice due to a proprietary rapid prototyping procedure established at TissUse. The versatile TissUse approach ...
Manufactured by:Cytosurge AG based inGlattbrugg, SWITZERLAND
Custom CRISPR cell line engineering service based on our FluidFM® ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Rodent disease models are widely used for a broad range of project objectives, which involve investigation of pathological process and mechanism of disease, pre-clinical tests of potential therapeutic agents, ...
Manufactured by:SCIREQ - an emka TECHNOLOGIES Company based inMontreal, QUEBEC (CANADA)
VAAD is a new innovative technique using the flexiVent, introduced to improve in vivo aerosol administrations for drug delivery and disease modelling. The VAAD approach minimizes subject-to-subject variability, and fosters a highly homogenous aerosol deposition within the lung. This optimized aerosol protocol is synced with mechanical ventilation to standardize features of the subject’s ...
by:Genuity Science based inBoston, MASSACHUSETTS (USA)
Collaborating with Genuity Science is seamless. We facilitate fully-resourced studies to ensure successful health research for you and your patients. We fully fund all resources required to successfully deliver Genuity Science clinical studies at a local level. Our studies minimize disruption to your clinic and participation for any volunteer involves only a single appointment with a short ...
Manufactured by:Cloud-Clone Corp. based inKaty, TEXAS (USA)
The development of human disease is very complex, to itself as experimental object to in-depth study of the mechanism of disease, the accumulation of clinical experience not only in time and space are limited and many experiments on the moral are restricted. Animal models can provides the basic platform for the study of safety research of drugs, biological products, medical polymer materials, ...
Manufactured by:Curi Bio based inSeattle, WASHINGTON (USA)
Curi Bio has a repository of iPSC’s for disease modeling and proprietary technologies for differentiating these cells into myoblasts and cardiomyocytes. Curi has developed in vitro 3D disease models for multiple disease phenotypes. In addition, Curi has the capability of generating new gene-edited iPSC models in ...
Manufactured by:SCIREQ - an emka TECHNOLOGIES Company based inMontreal, QUEBEC (CANADA)
Surgical skills are needed for all our implanted telemetry and for some in vitro isolated organs ...
Manufactured by:Mimetas B.V. based inLeiden, NETHERLANDS
Capture and understand human disease biology in vitro. The key to unlocking effective therapies for the unsolved diseases of our times is a deep understanding of human disease biology. To this end, MIMETAS aims to capture the essence of diseases in fit-for-purpose in vitro models. We are fully committed to reducing human disease complexity into functional and screenable ...
by:Selvita S.A. based inKrakow, POLAND
Having experience in both pharma and biotech R&D, we are well aware of what it means to discover a hit and transform it into a drug. You can best benefit from this “insider” experience through our integrated drug discovery services built ...
Manufactured by:Destiny Pharma plc based inBrighton, UNITED KINGDOM
Work on earlier programmes investigating infections in areas such as respiratory, dermal, ocular and biofilms carries on as research projects, including academic and/or commercial collaborations and grant funded ...
Manufactured by:CENTOGENE N.V. based inRostock, GERMANY
We work with partners to develop new disease models and new biomarkers of disease. We can also use our disease models to identify new drug targets and screen chemical compounds to identify potential new drug candidates. CENTOGENE provides companies with tools to accelerate drug discovery. From population screening studies that elucidate the prevalence of a rare disease to disease modeling, we are ...
by:elminda Ltd. based inHerzliya, ISRAEL
CNS drugs exhibit the lowest approval success rates due to multiple challenges such as lack of efficacy in early and advanced stages of development, Poor target selection / engagement, poor translation from pre-clinical models and disease heterogeneity. BNA may contribute in CNS research and drug development by adding new objective endpoints, assisting in understanding drug mechanism, identifying ...
Manufactured by:InnoSer Belgie NV based inDiepenbeek, BELGIUM
In vitro and in vivo methods to provide a study setup that thoroughly determines safety and efficacy. ...
by:Azafaros based inNaarden, NETHERLANDS
Azafaros B.V. is pioneering the development of innovative oral small molecule compounds addressing the pathological effects of metabolite accumulation in rare metabolic disorders. Their lead compound, nizubaglustat, leverages unique dual-mode action, making it a promising candidate for modifying diseases irrespective of patient genotypes. Notably effective against conditions such as GM1 and GM2 ...
Manufactured by:Nexelis based inSeattle, WASHINGTON (USA)
Custom In Vivo Models and Testing Solutions. Selecting the appropriate in vivo model for your assays is critical for the success of your preclinical research program. At Nexelis, a Q² Solutions Company, we designed and developed disease specific in vivo models alongside bespoke personalized model development services. Our wealth of experience and capabilities allows us to help answer our ...
by:Excelra based inIselin, NEW JERSEY (USA)
As the volume of biomedical data increases, so does the complexity of drug discovery and development programs. There’s a wealth of opportunity out there but capturing high-quality data and putting it to immediate productive use is often expensive and inefficient. We know that data alone can’t provide insight. You need more than just data. You need ...
Manufactured by:Nexelis based inSeattle, WASHINGTON (USA)
For R&D in Immunogenicity, Immuno-Oncology, and Cell and Gene Therapy. We have exceptional in vitro bioassay development services and support for early evaluation and screening of candidate therapeutics. Our highly experienced team will facilitate in silico immunogenicity assessment with epitope prediction to in vitro immunogenicity and immuno-functionality assays. ...
Manufactured by:Newcells Biotech Limited based inNewcastle Upon Tyne, UNITED KINGDOM
In vitro retinal disease modelling for retinal therapy. Newcells offers a fast and reliable in vitro safety and efficacy service for the evaluation of novel compounds for retinal therapy using complex human retinal organoid or RPE models developed in house. Both models are iPSC derived allowing gene-edited lines to be engineered using CRISPR/Cas9 for direct comparison between WT and mutant ...